These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. EU health ministers reject proposal for limited direct to consumer advertising. Watson R BMJ; 2003 Jun; 326(7402):1284. PubMed ID: 12805139 [No Abstract] [Full Text] [Related]
3. Europe reconsidering DTCA. Meek C CMAJ; 2007 May; 176(10):1405. PubMed ID: 17485687 [No Abstract] [Full Text] [Related]
4. European Commission may reform drug advertising legislation. Glass N Lancet; 2001 Jul; 358(9278):306. PubMed ID: 11498228 [No Abstract] [Full Text] [Related]
5. Advertisement of medicines. Br Med J; 1961 May; 1(5237):1470-1. PubMed ID: 14447327 [No Abstract] [Full Text] [Related]
6. Direct-to-consumer drug information in Europe. Ager B Lancet; 2007 Mar; 369(9564):822. PubMed ID: 17350444 [No Abstract] [Full Text] [Related]
8. US aims to tighten rules on direct-to-consumer drug ads. Vastag B Nat Biotechnol; 2007 Mar; 25(3):267. PubMed ID: 17344868 [No Abstract] [Full Text] [Related]
9. Efforts to ban direct-to-consumer advertising in New Zealand: a call to action. Hoffman JR; Cooper RJ Br J Gen Pract; 2003 Apr; 53(489):267-9. PubMed ID: 12879824 [No Abstract] [Full Text] [Related]
10. UK consumers reject direct advertising to patients by drug industry. Hunter M BMJ; 2002 Jun; 324(7351):1416. PubMed ID: 12068862 [No Abstract] [Full Text] [Related]
11. Direct-to-consumer advertising and shared liability for pharmaceutical manufacturers. Mello MM; Rosenthal M; Neumann PJ JAMA; 2003 Jan 22-29; 289(4):477-81. PubMed ID: 12533128 [No Abstract] [Full Text] [Related]
12. US Congress to consider limits on DTCA. Guthrie P CMAJ; 2007 May; 176(10):1404. PubMed ID: 17485685 [No Abstract] [Full Text] [Related]
13. Direct-to-consumer advertising of prescription drugs: European Commission persists in putting industry's interests first. Prescrire Int; 2013 Jan; 22(134):24-5, 27. PubMed ID: 23373084 [TBL] [Abstract][Full Text] [Related]
14. The FDA's restrictions against prescription drug advertising: more hindrance than help. Lorman AJ Healthspan; 1991 Nov; 8(10):3-7. PubMed ID: 10114942 [No Abstract] [Full Text] [Related]
15. Reorienting the course of medicines policy: actions are bearing fruit. Prescrire Int; 2003 Oct; 12(67):192-4. PubMed ID: 14619908 [TBL] [Abstract][Full Text] [Related]
16. New EU proposals ban communication of drug information through mass media. Watson R BMJ; 2011 Oct; 343():d6700. PubMed ID: 22016453 [No Abstract] [Full Text] [Related]
17. Prescription drug advertising--should states regulate what is false and misleading? Shaeffer J Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454 [No Abstract] [Full Text] [Related]
18. The pharmaceutical industry and disease mongering. Will industry's latest moves promote public health or private profit? McKechnie S BMJ; 2002 Jul; 325(7357):216; author reply 216. PubMed ID: 12143862 [No Abstract] [Full Text] [Related]
19. Legislative and non-legislative regulations concerning Rx drug advertisement in the European Union and the United States--comparative analysis. Czerw A; Religioni U Acta Pol Pharm; 2012; 69(4):779-87. PubMed ID: 22876622 [TBL] [Abstract][Full Text] [Related]
20. The Canadian approach to freedom of expression and the regulation of food and drug advertising. McNaughton EL; Goodridge CM Food Drug Law J; 2003; 58(3):521-36. PubMed ID: 14626988 [No Abstract] [Full Text] [Related] [Next] [New Search]